Patents Assigned to PharmacoGenetics, Ltd.
  • Patent number: 6972174
    Abstract: A method of genotyping single nucleotide polymorphisms (“SNP”) and point mutations in nucleic acid based on chain extension by polymerase. This invention is based on the fact that the nucleoside immediately 5? adjacent to any SNP/point mutation site is known, and the neighboring sequence immediately 3? adjacent to the site is also known. A primer complementary to the sequence directly adjacent to the SNP on the 3? side in a target polynucleotide is used for chain elongation. The polymerase reaction mixture contains one chain-terminating nucleotide having a base complementary to the nucleotide directly adjacent to the SNP on the 5? side in the target polynucleotide. An additional dNTP may be added to produce a primer with the maximum of a two-base extension. The resultant elongation/termination reaction products are analyzed for the length of chain extension of the primer, or for the amount of label incorporation from a labeled form of the terminator nucleotide.
    Type: Grant
    Filed: June 4, 2002
    Date of Patent: December 6, 2005
    Assignee: PharmacoGenetics, Ltd.
    Inventors: Hong Xue, Jeffrey Tze-Fei Wong
  • Publication number: 20030017487
    Abstract: A method of genotyping single nucleotide polymorphisms (“SNP”) and point mutations in nucleic acid based on chain extension by polymerase. This invention is based on the fact that the nucleoside immediately 5′ adjacent to any SNP/point mutation site is known, and the neighboring sequence immediately 3′ adjacent to the site is also known. A primer complementary to the sequence directly adjacent to the SNP on the 3′ side in a target polynucleotide is used for chain elongation. The polymerase reaction mixture contains one chain-terminating nucleotide having a base complementary to the nucleotide directly adjacent to the SNP on the 5′ side in the target polynucleotide. An additional dNTP may be added to produce a primer with the maximum of a two-base extension. The resultant elongation/termination reaction products are analyzed for the length of chain extension of the primer, or for the amount of label incorporation from a labeled form of the terminator nucleotide.
    Type: Application
    Filed: June 4, 2002
    Publication date: January 23, 2003
    Applicant: PharmacoGenetics, Ltd.
    Inventors: Hong Xue, Jeffrey Tze-Fei Wong